Diverse representation in clinical trials is critical in achieving greater equity and better healthcare outcomes. DLA Piper's Kirsten Axelsen and Sarah Schick are joined by Shazia Ahmad, Senior Director and Head of Patient and Physician Services at UBC, to discuss the importance of regulatory incentives to drive racial and ethnic diversity in clinical trials.
Podden och tillhörande omslagsbild på den här sidan tillhör
DLA Piper. Innehållet i podden är skapat av DLA Piper och inte av,
eller tillsammans med, Poddtoppen.